Wednesday, 20 August 2025
  
Login

Australia's most trusted
source of pharma news

Wednesday, 20 August 2025
News

Nine pharmas pitch new labels

Posted 15 August 2025 AM

Nine companies are a step closer to adding new labels to their drugs after the TGA accepted their Type C applications for review in June.

Moderna is looking to carve out a new niche for mRESVIA in the increasingly flooded RSV vaccine market by targeting younger Aussies. The TGA is considering extending the use of the mRNA vaccine, currently approved for certain adults from 60 years of age, for adults 18 through to 59 years of age who are at increased risk of RSV spreading to lower parts of the respiratory system, such as the lungs.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (3)

Sales & Customer Relations (14)

Clinical & Medical, R&D (12)

Regulatory, Pharmacovigilance & QA (5)

Devices (1)

Other (15)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.